From the Journals

Can Biomarkers Refine Psych Dx?

Emerging evidence suggests biologic signals may predict treatment response and improve outcomes.

Share

Amanda Miller, a pregnant neuroscientist in Pennsylvania, struggled with severe depression after the birth of her second child. Traditional psychiatric treatments failed until her primary care physician identified high autoimmune markers; she was diagnosed with lupus and began an anti-inflammatory steroid, alleviating both her physical and mental health issues. This prompted a discussion about the potential role of biomarkers in diagnosing and treating mental illnesses, a concept The American Psychiatric Association is exploring in its future DSM updates.

Original Source(s)

Can Biomarkers Refine Psych Dx?

  • by Jamie Ducharme

  • March 17, 2026

Related Content

US Adolescent Sleep Loss Worsens Over 16 Years

Increase was driven largely by rising rates of very short sleep among high school students, with trends seen across demographic and behavioral groups.

Side Effects: Medicine's Blind Spot

Medicine is having a week: new insights on nutrition training, a rethink of “spring fatigue,” evidence that avocados may support artery health, and an AI that can spot rare hormone tumors from a hand photo

Hidden Risk: Clinician Substance Use

Longitudinal Swedish study finds physicians and nurses reporting problem drinking or illicit drug use had about twice the risk of rating their care as poor 1 year later